AMC Nishiumeda Clinic

Osaka 530-0001

0 studies enrolling now · 10 studies all time

What they study most

Alzheimer Disease, Chronic Kidney Disease, Dyslipidemias, Hyperlipoproteinemia, Lipid Metabolism Disorders, Lipoprotein Disorder, Lower Respiratory Tract Illness, Metabolic Diseases, Obesity, Overweight, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. — Running, not enrolling
• A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) — Running, not enrolling
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight — Completed
• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
• A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin — Completed
• A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)] — Completed
• A Study of LY3561774 in Participants With Mixed Dyslipidemia — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight — Completed